RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC after failure of platinum-based chemotherapy in Brazil

Trial Identifier: D133HR00041
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: June 2026
Study Completion Date: June 2026
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil, Minas Gerais Belo Horizonte, Minas Gerais, Brazil, 30110-934
Brazil, Minas Gerais Belo Horizonte, Minas Gerais, Brazil, 30380-420
Brazil, Rio Grande do Norte Natal, Rio Grande do Norte, Brazil, 59062-000
Brazil, Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil, 90560-032
Brazil, Sao Paulo Sao Jose do Rio Preto, Sao Paulo, Brazil, 15090-000
Brazil, Sao Paulo Sao Paulo, Brazil, 05652-900
Brazil, Sao Paulo Sao Paulo, Brazil, 01323-020
Brazil, Sao Paulo Sao Paulo, Brazil, 01308-050
Brazil, Sao Paulo Sao Paulo, Brazil, 01333-010
Brazil, Sao Paulo Sao Paulo, Brazil, 01509-010
Brazil, Sao Paulo Sao Paulo, Brazil, 01323-001